Mainz Coronary Angiography Patient Registry Including Absorb Scaffold Therapy Tracking Coronary Slow-Flow and Microvascular Diseases Over 10 Years

What this Trial Is About

This observational study focuses on patients undergoing coronary angiography, including those treated with the Absorb bioresorbable scaffold for new narrowing of coronary arteries. The goal is to collect prospective data on coronary artery disease and microvascular dysfunction, with additional retrospective data included anonymously. The study is sponsored by Johannes Gutenberg University Mainz and aims to understand major cardiovascular events over time. Participants include consecutive patients undergoing coronary angiography at the University Medical Center Mainz, with no specific inclusion criteria beyond clinical indication for the procedure. Patients receiving the Absorb scaffold are also included based on clinical need. Blood samples may be collected for further analysis if slow coronary flow is observed during the initial procedure. Participants will be followed up by telephone at multiple time points 3, 6, 9, and 12 months, then 2, 5, and 10 years after their procedure. The main outcomes measured include major adverse cardiovascular events and other cardiovascular endpoints over a 10-year period. Retrospective data from 1000 patients will be anonymously included without additional study procedures. The registry collects routine clinical data to support long-term cardiovascular research.

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry